
New evidence provides ODs with increasingly accurately gauge of patients’ diabetes control and risk of vision loss.

New evidence provides ODs with increasingly accurately gauge of patients’ diabetes control and risk of vision loss.

A comprehensive approach to treatment is critical to help patients with comprehensive disease.

AI technology promises to improve access, outcomes, and efficiency.

For ODs during the COVID-19 pandemic, failure is not an option.


An eyecare group in a New York City hospital shares its protocol.







Awardees were selected from a robust field of nominees.


Unemployment, economies, and response aggressiveness compared.

Studies allow optometrists to tell patients that there is hope.

Asking patients about occupation can lead ODs into new diagnosis territory

Remember the ubiquitous nature of digital dry eye disease in your practice.

Contact lens educators from six countries honored.



Health and safety are prioritized as COVID-19 takes in-person meetings online.

Axial length, keratometry and the IOL constant in calculating IOL power


A tricky case posed some diagnostic challenges until an unexpected error message presented




Results from the EAGLE and ZAP clinical trials provide answers to lingering questions.